Hanna Wiktorin-Grauers

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma.

Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma.

Journal: ImmunoTargets and therapy
Published: January 20, 2026

Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients.

Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients.

Journal: Biomarker research
Published: January 09, 2026

LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial.

LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial.

Journal: Nature communications
Published: September 17, 2025

Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines.

Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines.

Journal: Human vaccines & immunotherapeutics
Published: January 23, 2025

Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer.

Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer.

Journal: Cancer research communications
Published: January 12, 2024

Presence of MDSC associates with impaired antigen-specific T cell reactivity following COVID-19 vaccination in cirrhotic patients.

Presence of MDSC associates with impaired antigen-specific T cell reactivity following COVID-19 vaccination in cirrhotic patients.

Journal: Frontiers in immunology
Published: September 01, 2023

An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis.

An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis.

Journal: Oncoimmunology
Published: September 01, 2022

Induction and subsequent decline of S1-specific T cell reactivity after COVID-19 vaccination.

Induction and subsequent decline of S1-specific T cell reactivity after COVID-19 vaccination.

Journal: Clinical immunology (Orlando, Fla.)
Published: August 26, 2022

Transient and durable T cell reactivity after COVID-19.

Transient and durable T cell reactivity after COVID-19.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 20, 2022

Rapid Cytokine Release Assays for Analysis of Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells in Whole Blood.

Rapid Cytokine Release Assays for Analysis of Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells in Whole Blood.

Journal: The Journal of infectious diseases
Published: October 12, 2021

Impact of IL-1β and the IL-1R antagonist on relapse risk and survival in AML patients undergoing immunotherapy for remission maintenance.

Impact of IL-1β and the IL-1R antagonist on relapse risk and survival in AML patients undergoing immunotherapy for remission maintenance.

Journal: Oncoimmunology
Published: August 09, 2021

NOX2-Derived Reactive Oxygen Species in Cancer.

NOX2-Derived Reactive Oxygen Species in Cancer.

Journal: Oxidative medicine and cellular longevity
Published: August 02, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026